公司資料
Indivior 股價、新聞與催化劑
- 股票代碼:
- INDV
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United Kingdom and listed in the U
股票表現
39.08 USD (+0.18%)
收盤價
最後更新: 2026年8月17日
3.98B USD
市值
股價為何變動
As of Aug 17, 2026, INDV was little changed and closed at $39.08. No new same-company headline was identified in the current news window.
公司概覽
Addiction Medicine
Indivior develops and commercializes medicines for substance-use disorders. Its strategy emphasizes long-acting formulations that support sustained treatment while reducing the burden and diversion risks associated with daily medication.
SUBLOCADE Franchise
SUBLOCADE is a monthly extended-release buprenorphine injection for opioid-use disorder and is the company’s primary commercial product. The formulation is administered by healthcare professionals and provides continuous buprenorphine exposure over the dosing interval.
Focused Portfolio Strategy
Indivior is concentrating resources on its marketed addiction franchise after deciding not to internally advance INDV-2000 and not to pursue Phase 3 development of INDV-6001. It retains potential U.S. commercial rights to a future viable product developed by the INDV-6001 licensor.
未來催化劑
近期新聞
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。